4.7 Review

The CD38 glycohydrolase and the NAD sink: implications for pathological conditions

期刊

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
卷 322, 期 3, 页码 C521-C545

出版社

AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajpcell.00451.2021

关键词

CD38; diseases; NAD metabolism

资金

  1. Helen Diller Family Foundation
  2. Glenn Foundation for Medical Research via the Paul F. Glenn Laboratories for the Biology of Aging
  3. Calico Life Sciences LLC
  4. National Institute on Aging [AG-26094, AG58812]
  5. National Cancer Institute [CA233790]

向作者/读者索取更多资源

Nicotinamide adenine dinucleotide (NAD) plays a crucial role in cellular processes and its homeostasis is essential for health and disease. CD38 enzyme is a key regulator of NAD homeostasis and dysregulation of CD38 can contribute to various diseases.
Nicotinamide adenine dinucleotide (NAD) acts as a cofactor in several oxidation-reduction (redox) reactions and is a substrate for a number of nonredox enzymes. NAD is fundamental to a variety of cellular processes including energy metabolism, cell signaling, and epigenetics. NAD homeostasis appears to be of paramount importance to health span and longevity, and its dysregulation is associated with multiple diseases. NAD metabolism is dynamic and maintained by synthesis and degradation. The enzyme CD38, one of the main NAD-consuming enzymes, is a key component of NAD homeostasis. The majority of CD38 is localized in the plasma membrane with its catalytic domain facing the extracellular environment, likely for the purpose of controlling systemic levels of NAD. Several cell types express CD38, but its expression predominates on endothelial cells and immune cells capable of infiltrating organs and tissues. Here we review potential roles of CD38 in health and disease and postulate ways in which CD38 dysregulation causes changes in NAD homeostasis and contributes to the pathophysiology of multiple conditions. Indeed, in animal models the development of infectious diseases, autoimmune disorders, fibrosis, metabolic diseases, and age-associated diseases including cancer, heart disease, and neurodegeneration are associated with altered CD38 enzymatic activity. Many of these conditions are modified in CD38-deficient mice or by blocking CD38 NADase activity. In diseases in which CD38 appears to play a role, CD38-dependent NAD decline is often a common denominator of pathophysiology. Thus, understanding dysregulation of NAD homeostasis by CD38 may open new avenues for the treatment of human diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据